These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 1647085)

  • 21. The human immunodeficiency virus(HIV) inhibitor 9-(2-phosphonylmethoxyethyl)adenine (PMEA) is a strong inducer of differentiation of several tumor cell lines.
    Balzarini J; Verstuyf A; Hatse S; Goebels J; Sobis H; Vandeputte M; De Clercq E
    Int J Cancer; 1995 Mar; 61(1):130-7. PubMed ID: 7705926
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antiretrovirus specificity and intracellular metabolism of 2',3' -didehydro-2',3'-dideoxythymidine (stavudine) and its 5'-monophosphate triester prodrug So324.
    Balzarini J; Egberink H; Hartmann K; Cahard D; Vahlenkamp T; Thormar H; De Clercq E; McGuigan C
    Mol Pharmacol; 1996 Nov; 50(5):1207-13. PubMed ID: 8913352
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Anti-retroviral and pharmacological properties of 9-(2-phosphonylmethoxyethyl) adenine (PMEA).
    Balzarini J
    Adv Exp Med Biol; 1994; 370():459-64. PubMed ID: 7660950
    [No Abstract]   [Full Text] [Related]  

  • 24. Synthesis, in vitro anti-human immunodeficiency virus structure-activity relationships and biological stability of 5'-O-myristoyl analogue derivatives of 3'-azido-2',3'-dideoxythymidine (AZT) as potential prodrugs.
    Parang K; Wiebe LI; Knaus EE
    Antivir Chem Chemother; 1998 Jul; 9(4):311-23. PubMed ID: 9875410
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characterization of the activation pathway of phosphoramidate triester prodrugs of stavudine and zidovudine.
    Saboulard D; Naesens L; Cahard D; Salgado A; Pathirana R; Velazquez S; McGuigan C; De Clercq E; Balzarini J
    Mol Pharmacol; 1999 Oct; 56(4):693-704. PubMed ID: 10496951
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacokinetic and antiretroviral activity in mice of oral [P(1),P(2)-bis[2-(adenin-9-yl)ethoxymethyl]phosphonate], a prodrug of 9-(2-phosphonylmethoxyethyl)adenine.
    Rossi L; Dominici S; Serafini S; Casabianca A; Cerasi A; Chiarantini L; Celeste AG; Cappellacci L; Franchetti P; Grifantini M; Magnani M
    J Antimicrob Chemother; 2002 Sep; 50(3):365-74. PubMed ID: 12205061
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibitory effects of 9-(2-phosphonylmethoxyethyl)adenine and 3'-azido-2',3'-dideoxythymidine on tumor development in mice inoculated intracerebrally with Moloney murine sarcoma virus.
    Balzarini J; Sobis H; Naesens L; Vandeputte M; De Clercq E
    Int J Cancer; 1990 Mar; 45(3):486-9. PubMed ID: 2307539
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 9-(2-Phosphonylmethoxyethyl)adenine in the treatment of murine acquired immunodeficiency disease and opportunistic herpes simplex virus infections.
    Gangemi JD; Cozens RM; De Clercq E; Balzarini J; Hochkeppel HK
    Antimicrob Agents Chemother; 1989 Nov; 33(11):1864-8. PubMed ID: 2482011
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intracellular metabolism and mechanism of anti-retrovirus action of 9-(2-phosphonylmethoxyethyl)adenine, a potent anti-human immunodeficiency virus compound.
    Balzarini J; Hao Z; Herdewijn P; Johns DG; De Clercq E
    Proc Natl Acad Sci U S A; 1991 Feb; 88(4):1499-503. PubMed ID: 1705039
    [TBL] [Abstract][Full Text] [Related]  

  • 30. New trends in antiviral chemotherapy.
    De Clercq E
    Arch Int Physiol Biochim; 1979 May; 87(2):353-95. PubMed ID: 92947
    [No Abstract]   [Full Text] [Related]  

  • 31. 2',3'-didehydro-2',3'-dideoxy-5-chlorocytidine is a selective anti-retrovirus agent.
    Balzarini J; Van Aerschot A; Herdewijn P; De Clercq E
    Biochem Biophys Res Commun; 1989 Nov; 164(3):1190-7. PubMed ID: 2590197
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Use of recombinant retroviruses to characterize the activity of antiretroviral compounds.
    Stair RK; Nelson CJ; Mellors JW
    J Virol; 1991 Nov; 65(11):6339-42. PubMed ID: 1920637
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Concise overview of the clinical pharmacokinetics of dideoxynucleoside antiretroviral agents.
    Burger DM; Meenhorst PL; Beijnen JH
    Pharm World Sci; 1995 Mar; 17(2):25-30. PubMed ID: 7795555
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vitro toxicity and metabolism of 2',3'-dideoxycytidine, an inhibitor of human immunodeficiency virus infectivity.
    Brandi G; Rossi L; Schiavano GF; Salvaggio L; Albano A; Magnani M
    Chem Biol Interact; 1991; 79(1):53-64. PubMed ID: 1647888
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Human red blood cells as bioreactors for the release of 2',3'-dideoxycytidine, an inhibitor of HIV infectivity.
    Magnani M; Bianchi M; Rossi L; Stocchi V
    Biochem Biophys Res Commun; 1989 Oct; 164(1):446-52. PubMed ID: 2553018
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antiretroviral-drug concentrations in semen.
    Gallicano K
    Antimicrob Agents Chemother; 2000 Apr; 44(4):1117-8. PubMed ID: 10799009
    [No Abstract]   [Full Text] [Related]  

  • 37. [Anti-retroviral activity and molecular-biochemical action mechanism of 2',3'-dideoxynucleoside analogs and 9-(2-phosphonylmethoxyethyl) purine derivatives].
    Balzarini J
    Verh K Acad Geneeskd Belg; 1991; 53(1):61-98. PubMed ID: 1647085
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Metabolism and mechanism of antiretroviral action of purine and pyrimidine derivatives.
    Balzarini J
    Pharm World Sci; 1994 Apr; 16(2):113-26. PubMed ID: 8032337
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 2',3'-Dideoxycytidine: regulation of its metabolism and anti-retroviral potency by natural pyrimidine nucleosides and by inhibitors of pyrimidine nucleotide synthesis.
    Balzarini J; Cooney DA; Dalal M; Kang GJ; Cupp JE; DeClercq E; Broder S; Johns DG
    Mol Pharmacol; 1987 Dec; 32(6):798-806. PubMed ID: 2826994
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 2',3'-Dideoxycytidine toxicity in cultured human CEM T lymphoblasts: effects of combination with 3'-azido-3'-deoxythymidine and thymidine.
    Törnevik Y; Eriksson S
    Mol Pharmacol; 1990 Aug; 38(2):237-43. PubMed ID: 2166904
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.